• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有机阳离子转运体1(OCT1;SLC22A1)竞争性和非竞争性配体的发现。

Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1).

作者信息

Chen Eugene C, Khuri Natalia, Liang Xiaomin, Stecula Adrian, Chien Huan-Chieh, Yee Sook Wah, Huang Yong, Sali Andrej, Giacomini Kathleen M

机构信息

Department of Bioengineering and Therapeutic Sciences, University of California , San Francisco, California 94143, United States.

Optivia Biotechnology , Menlo Park, California 94025, United States.

出版信息

J Med Chem. 2017 Apr 13;60(7):2685-2696. doi: 10.1021/acs.jmedchem.6b01317. Epub 2017 Mar 15.

DOI:10.1021/acs.jmedchem.6b01317
PMID:28230985
Abstract

Organic cation transporter 1 (OCT1) plays a critical role in the hepatocellular uptake of structurally diverse endogenous compounds and xenobiotics. Here we identified competitive and noncompetitive OCT1-interacting ligands in a library of 1780 prescription drugs by combining in silico and in vitro methods. Ligands were predicted by docking against a comparative model based on a eukaryotic homologue. In parallel, high-throughput screening (HTS) was conducted using the fluorescent probe substrate ASP in cells overexpressing human OCT1. Thirty competitive OCT1 ligands, defined as ligands predicted in silico as well as found by HTS, were identified. Of the 167 ligands identified by HTS, five were predicted to potentially cause clinical drug interactions. Finally, virtual screening of 29 332 metabolites predicted 146 competitive OCT1 ligands, of which an endogenous neurotoxin, 1-benzyl-1,2,3,4-tetrahydroisoquinoline, was experimentally validated. In conclusion, by combining docking and in vitro HTS, competitive and noncompetitive ligands of OCT1 can be predicted.

摘要

有机阳离子转运体1(OCT1)在肝细胞摄取结构多样的内源性化合物和外源性物质过程中发挥着关键作用。在此,我们通过结合计算机模拟和体外实验方法,在一个包含1780种处方药的文库中鉴定出了竞争性和非竞争性的OCT1相互作用配体。通过与基于真核同源物的比较模型进行对接来预测配体。同时,在过表达人OCT1的细胞中使用荧光探针底物ASP进行高通量筛选(HTS)。鉴定出了30种竞争性OCT1配体,即通过计算机模拟预测并经HTS发现的配体。在HTS鉴定出的167种配体中,有5种被预测可能会引起临床药物相互作用。最后,对29332种代谢产物进行虚拟筛选,预测出146种竞争性OCT1配体,其中一种内源性神经毒素1-苄基-1,2,3,4-四氢异喹啉经实验验证。总之,通过结合对接和体外HTS,可以预测OCT1的竞争性和非竞争性配体。

相似文献

1
Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1).有机阳离子转运体1(OCT1;SLC22A1)竞争性和非竞争性配体的发现。
J Med Chem. 2017 Apr 13;60(7):2685-2696. doi: 10.1021/acs.jmedchem.6b01317. Epub 2017 Mar 15.
2
Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1.阿片类药物作为遗传高度变异的有机阳离子转运蛋白 OCT1 的底物和抑制剂。
J Med Chem. 2019 Nov 14;62(21):9890-9905. doi: 10.1021/acs.jmedchem.9b01301. Epub 2019 Nov 4.
3
Interaction between the zebrafish (Danio rerio) organic cation transporter 1 (Oct1) and endo- and xenobiotics.斑马鱼(Danio rerio)有机阳离子转运体1(Oct1)与内源性和外源性物质之间的相互作用。
Aquat Toxicol. 2017 Jun;187:18-28. doi: 10.1016/j.aquatox.2017.03.012. Epub 2017 Mar 18.
4
Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions.有机阳离子转运蛋白 OCT1 抑制剂的基因型依赖性效应:预测二甲双胍的相互作用。
Pharmacogenomics J. 2011 Dec;11(6):400-11. doi: 10.1038/tpj.2010.54. Epub 2010 Jun 22.
5
Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration.吗啡是有机阳离子转运蛋白 OCT1 的底物,编码 OCT1 基因的多态性影响可待因给药后吗啡的药代动力学。
Biochem Pharmacol. 2013 Sep 1;86(5):666-78. doi: 10.1016/j.bcp.2013.06.019. Epub 2013 Jul 5.
6
Protein Kinase C-Independent Inhibition of Organic Cation Transporter 1 Activity by the Bisindolylmaleimide Ro 31-8220.双吲哚马来酰亚胺Ro 31-8220对有机阳离子转运体1活性的蛋白激酶C非依赖性抑制作用
PLoS One. 2015 Dec 10;10(12):e0144667. doi: 10.1371/journal.pone.0144667. eCollection 2015.
7
Atypical Substrates of the Organic Cation Transporter 1.有机阳离子转运蛋白 1 的非典型底物。
Biomolecules. 2022 Nov 9;12(11):1664. doi: 10.3390/biom12111664.
8
Amino acids in transmembrane helix 1 confer major functional differences between human and mouse orthologs of the polyspecific membrane transporter OCT1.跨膜螺旋 1 中的氨基酸赋予多特异性膜转运蛋白 OCT1 的人源和鼠源同源物之间的主要功能差异。
J Biol Chem. 2022 Jun;298(6):101974. doi: 10.1016/j.jbc.2022.101974. Epub 2022 Apr 22.
9
Multispecific Organic Cation Transporter 1 (OCT1) from Bos taurus Has High Affinity and Slow Binding Kinetics towards Prostaglandin E2.来自牛的多特异性有机阳离子转运体1(OCT1)对前列腺素E2具有高亲和力和缓慢的结合动力学。
PLoS One. 2016 Apr 5;11(4):e0152969. doi: 10.1371/journal.pone.0152969. eCollection 2016.
10
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.药物抑制肝脏特异性人类有机阳离子转运蛋白1的结构要求
J Med Chem. 2008 Oct 9;51(19):5932-42. doi: 10.1021/jm8003152. Epub 2008 Sep 13.

引用本文的文献

1
Structural insights into human organic cation transporter 1 transport and inhibition.人类有机阳离子转运体1转运与抑制的结构见解
Cell Discov. 2024 Mar 15;10(1):30. doi: 10.1038/s41421-024-00664-1.
2
Medicinal Polypharmacology in the Clinic - Translating the Polypharmacolome into Therapeutic Benefit.临床中的药物多药理学——将多药药理学转化为治疗益处。
Pharm Res. 2024 Mar;41(3):411-417. doi: 10.1007/s11095-024-03656-8. Epub 2024 Feb 16.
3
Stereoselective Inhibition of High- and Low-Affinity Organic Cation Transporters.立体选择性抑制高亲和性和低亲和性有机阳离子转运体。
Mol Pharm. 2023 Dec 4;20(12):6289-6300. doi: 10.1021/acs.molpharmaceut.3c00691. Epub 2023 Nov 14.
4
Molecular basis of polyspecific drug and xenobiotic recognition by OCT1 and OCT2.OCT1 和 OCT2 对多特异性药物和外源性化学物质识别的分子基础。
Nat Struct Mol Biol. 2023 Jul;30(7):1001-1011. doi: 10.1038/s41594-023-01017-4. Epub 2023 Jun 8.
5
Molecular basis of polyspecific drug binding and transport by OCT1 and OCT2.有机阳离子转运体1和2介导多特异性药物结合与转运的分子基础
bioRxiv. 2023 Mar 16:2023.03.15.532610. doi: 10.1101/2023.03.15.532610.
6
Genetic Variation in and Affects Amlodipine Pharmacokinetics and Safety.[基因名称1]和[基因名称2]中的基因变异影响氨氯地平的药代动力学和安全性。 (注:原文中两个基因名称缺失,需根据实际情况补充完整)
Pharmaceutics. 2023 Jan 25;15(2):404. doi: 10.3390/pharmaceutics15020404.
7
Involvement of Transporters in Intestinal Drug-Drug Interactions of Oral Targeted Anticancer Drugs Assessed by Changes in Drug Absorption Time.通过药物吸收时间变化评估转运体在口服靶向抗癌药物肠道药物相互作用中的作用。
Pharmaceutics. 2022 Nov 17;14(11):2493. doi: 10.3390/pharmaceutics14112493.
8
Multitargeting nature of muscarinic orthosteric agonists and antagonists.毒蕈碱型正构激动剂和拮抗剂的多靶点特性。
Front Physiol. 2022 Sep 6;13:974160. doi: 10.3389/fphys.2022.974160. eCollection 2022.
9
Amino acids in transmembrane helix 1 confer major functional differences between human and mouse orthologs of the polyspecific membrane transporter OCT1.跨膜螺旋 1 中的氨基酸赋予多特异性膜转运蛋白 OCT1 的人源和鼠源同源物之间的主要功能差异。
J Biol Chem. 2022 Jun;298(6):101974. doi: 10.1016/j.jbc.2022.101974. Epub 2022 Apr 22.
10
Relationships between Inhibition, Transport and Enhanced Transport via the Organic Cation Transporter 1.有机阳离子转运体 1 的抑制、转运和增强转运之间的关系。
Int J Mol Sci. 2022 Feb 11;23(4):2007. doi: 10.3390/ijms23042007.